I agree. I reread the transcript. I think his talk of GIA in Europe is the ultimate head/pump fake. He mentioned holistic and value for shareholders numerous times. Seems like he is dropping nuggets of BO and maybe he is signaling to others to get your bids up.
Reread the transcript and pay attention to how many times he mentions holistic.
We need a settlement ASAP.
"The aim is to put ourselves in a position to be able to make the right decision for our shareholders based upon a number of different factors in a holistic manner for shareholder value."
"....a decision with regarding partnering in Europe will be a holistic decision, including many factors. And some of what you've described as considerations I would put under that holistic view of optionality and flexibility, but it's all this is in terms of creation of long-term value and we need to pull that together and see what makes the most sense for our shareholders by the time that we're making that decision."
"The U.S. litigation doesn't directly affect the approval in Europe, doesn't directly affect the market opportunity in Europe, doesn't affect the reimbursement directly in Europe. But it does reflect that holistic view of corporate value and optionality and all of those considerations will be put forward. At this point in time, we're continuing to develop relationships with key opinion leaders in Europe and appreciating the support there as evidenced by the two medical studies that have already included us and VASCEPA in their guidelines but continuing to advance scale for growth, doing some pharmacoeconomic analysis for reimbursement in Europe. And all of those inputs will also factor into our decision making. So, it is a holistic perspective."
"Again, at this point in time, we're just trying to let shareholders and all the parties know that we're evaluating and our aim is to do what is in the best interest of shareholders on a long-term basis from a holistic perspective."
